nightmare
30-12-2004, Thu 12:14 AM
طلوع دولار بعشر دقايق من سعر الاغلاق والسبب تعاون مع الشهيره بروكتر آند قامبل
NOVN Noven Pharma earns $3 mln milestone payment under P&G collaboration
Co announces that it has earned a $3.0 mln success fee for attaining a development milestone under its development collaboration with P&G Pharmaceuticals, a subsidiary of Procter & Gamble (PG). NOVN expects to report the $3.0 mln success fee as license and contract revs for the qtr ending Dec 31, 2004. In light of the success fee, the co expects its full-year 2004 EPS to be $0.45-$0.50 (consensus $0.44) and its 2004 net revs to exceed 2003 levels
شتقول عن الخبر وتاثيره بوناصر غدا على السهم؟
NOVN Noven Pharma earns $3 mln milestone payment under P&G collaboration
Co announces that it has earned a $3.0 mln success fee for attaining a development milestone under its development collaboration with P&G Pharmaceuticals, a subsidiary of Procter & Gamble (PG). NOVN expects to report the $3.0 mln success fee as license and contract revs for the qtr ending Dec 31, 2004. In light of the success fee, the co expects its full-year 2004 EPS to be $0.45-$0.50 (consensus $0.44) and its 2004 net revs to exceed 2003 levels
شتقول عن الخبر وتاثيره بوناصر غدا على السهم؟